JSC “Farmak” will defend its intellectual property rights to the well-known trademark Corvalol Corvalolum at the hearing of the Grand Chamber of the Supreme Court of Ukraine scheduled for June 25, 2019.
JSC “Farmak” stands for a civilized competition and defends its rights to the well-known trademark Corvalol Corvalolum.
The hearing will be held at 04:00 p.m. at 8 Pylypa Orlyka Str., at the room of the Supreme Court.
It should be reminded that having examined the appeal of Pharmaceutical Firm “Darnitsa”, Kyiv Commercial Court of Appeal quashed the decision of the Appeals Chamber of the Ministry of Economic Development and Trade on the recognition of CORVALOL CORVALOLUM as well-known trademark.
The motions filed by both the Ministry of Economic Development and Trade as the defendant, and JSC “Farmak” as the third party were dismissed, evidencing biased proceedings in the appellate instance.
Historically, Farmak has owned the trademark “CORVALOL”, manufactured since 1960. “Corvalol” was developed in 1960 by Lomonosov Kyiv Chemical and Pharmaceutical Plant, the successor of which is JSC “Farmak”.
JSC “Farmak” has been established on the basis of Lomonosov Kyiv Chemical and Pharmaceutical Plant in 1925, specialized in manufacturing of pharmaceutical substances and radiopaque contrast agents in the territory of the former Soviet Union.
A new stage of the company’s development began after the transformation of the chemical plant into a robust pharmaceutical company manufacturing finished dosage forms in 1995.
Preparation for manufacturing of Corvalol was initiated by Lomonosov Kyiv Chemical and Pharmaceutical Plant, the successor of which is JSC “Farmak”.
The medicinal product was developed by Senior Chemist V.Ya. Yakovleva.
The first batch of Corvalol was released under the order of Lomonosov Kyiv Chemical and Pharmaceutical Plant dated October 15, 1960.
Since then, Lomonosov Kyiv Chemical and Pharmaceutical Plant has been the only manufacturer of Corvalol in the territory of the former USSR.
Since 1991, JSC “Farmak” has been the only manufacturer of this medicinal product in the former Soviet Union.
Furthermore, Corvalol trademark is protected in 15 countries of Europe and Central Asia: Germany, Poland, Lithuania, Estonia, Latvia, Belarus, Moldova, Romania, Bulgaria, Turkmenistan, Armenia, Georgia, Azerbaijan, Tajikistan, Kyrgyzstan, and Kazakhstan.
The use of the trademark Corvalol Corvalolum is generally confirmed by packaging for the period from 1991 to 2001 inclusive.
The authoritative Forbes publication included Farmak Supervisory Board Chairman Filya Zhebrovska in its global “50 Over 50” list: EMEA 2022. The businesswoman was joined by actress Judi Dench, designer Donatella Versace, president of the European Central Bank Christine Lagarde and other prominent figures. However, Filya Zhebrovska is the only Ukrainian woman...
Farmak, along with JTI, SoftServe, Fozzy Group and others, has been included in the list of 50 best employers of Ukraine compiled by the authoritative Forbes magazine and the Work.ua job search website. The companies have been evaluated by the jury according to 23 indicators falling under the following 8 criteria: Reputation and loyalty – the willingness of ...
Yevheniia Piddubna, Director for Corporate Communications of Farmak, was included in the list of the country’s best GR* managers compiled by the prestigious magazine “TOP-100. Ratings of the Largest”. GR specialists should primarily focus on establishing communication between business and the authorities for the joint and mutually beneficial development of t...